Sat, 15 Aug 2026

short seller

fraud

Blue Orca: HK-listed China Medical System exaggerates financial performance

FutureCFO Editors February 6, 2020

Blue Orca said today that aggregate net profits at China Medical System’s subsidiaries in China were 49% less than reported

fraud

HK-listed firm accused of fraud: Shares fell 24.8% before trading halt

FutureCFO Editors June 24, 2019

Short seller Bonitas Research accused Hong Kong-listed Bosideng (HKEx: 3998) of public market fraud, which resulted in the firm’s shares

Recent posts

Rewiring finance from expert to strategic partner

Where autonomous finance delivers measurable value

Finance teams: Managing two priorities at once

Singapore finance leaders lead in operationalising AI in finance

Singapore CFOs seek to lead on value creation

Transforming finance to align with business priorities and market dynamics

Subscribe